Mettler-Toledo International (NYSE:MTD) Rating Lowered to “Hold” at Wall Street Zen

Mettler-Toledo International (NYSE:MTD) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday.

MTD has been the subject of several other research reports. Morgan Stanley started coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price objective for the company. Citigroup upped their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective on the stock in a research report on Monday, December 15th. Barclays reduced their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Finally, Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $1,441.67.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,370.92 on Friday. The company has a market cap of $28.01 billion, a price-to-earnings ratio of 34.19, a price-to-earnings-growth ratio of 4.14 and a beta of 1.41. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,525.17. The stock’s 50-day moving average is $1,432.30 and its 200-day moving average is $1,351.89.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the prior year, the company earned $10.21 EPS. The company’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Research analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 236 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. This represents a 59.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Patrick Kaltenbach sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the sale, the chief executive officer owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This trade represents a 35.27% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 19,565 shares of company stock valued at $28,683,737. 1.94% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Mettler-Toledo International by 1.3% in the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after buying an additional 34,466 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after acquiring an additional 376,419 shares during the last quarter. Capital International Investors grew its holdings in Mettler-Toledo International by 1.2% during the 3rd quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock worth $1,055,203,000 after acquiring an additional 10,395 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Mettler-Toledo International by 10.7% in the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after purchasing an additional 76,478 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after purchasing an additional 3,383 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.